Cargando…
Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632469/ https://www.ncbi.nlm.nih.gov/pubmed/26531194 http://dx.doi.org/10.1186/s40478-015-0245-8 |
_version_ | 1782399038095622144 |
---|---|
author | Zivkovic, Aleksandar R. Sedlaczek, Oliver von Haken, Rebecca Schmidt, Karsten Brenner, Thorsten Weigand, Markus A. Bading, Hilmar Bengtson, C. Peter Hofer, Stefan |
author_facet | Zivkovic, Aleksandar R. Sedlaczek, Oliver von Haken, Rebecca Schmidt, Karsten Brenner, Thorsten Weigand, Markus A. Bading, Hilmar Bengtson, C. Peter Hofer, Stefan |
author_sort | Zivkovic, Aleksandar R. |
collection | PubMed |
description | Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsis using lipopolysaccharide (LPS) injections to induce endotoxemia in rats, followed by electrophysiological recordings in brain slices. Endotoxemia induced a deficit in long term potentiation which was completely reversed by apamin, a blocker of small conductance calcium-activated potassium (SK) channels, and partly restored by treatment with physostigmine (eserine), an acetylcholinesterase inhibitor, or TBPB, a selective M1 muscarinic acetylcholine receptor agonist. These results suggest a novel role for SK channels in the etiology of endotoxemia and explain why boosting cholinergic function restores deficits in synaptic plasticity. Drugs which enhance cholinergic or M1 activity in the brain may prove beneficial in treatment of septic delirium in the intensive care unit. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0245-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4632469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46324692015-11-05 Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity Zivkovic, Aleksandar R. Sedlaczek, Oliver von Haken, Rebecca Schmidt, Karsten Brenner, Thorsten Weigand, Markus A. Bading, Hilmar Bengtson, C. Peter Hofer, Stefan Acta Neuropathol Commun Research Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsis using lipopolysaccharide (LPS) injections to induce endotoxemia in rats, followed by electrophysiological recordings in brain slices. Endotoxemia induced a deficit in long term potentiation which was completely reversed by apamin, a blocker of small conductance calcium-activated potassium (SK) channels, and partly restored by treatment with physostigmine (eserine), an acetylcholinesterase inhibitor, or TBPB, a selective M1 muscarinic acetylcholine receptor agonist. These results suggest a novel role for SK channels in the etiology of endotoxemia and explain why boosting cholinergic function restores deficits in synaptic plasticity. Drugs which enhance cholinergic or M1 activity in the brain may prove beneficial in treatment of septic delirium in the intensive care unit. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0245-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-04 /pmc/articles/PMC4632469/ /pubmed/26531194 http://dx.doi.org/10.1186/s40478-015-0245-8 Text en © Zivkovic et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zivkovic, Aleksandar R. Sedlaczek, Oliver von Haken, Rebecca Schmidt, Karsten Brenner, Thorsten Weigand, Markus A. Bading, Hilmar Bengtson, C. Peter Hofer, Stefan Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title | Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title_full | Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title_fullStr | Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title_full_unstemmed | Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title_short | Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
title_sort | muscarinic m1 receptors modulate endotoxemia-induced loss of synaptic plasticity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632469/ https://www.ncbi.nlm.nih.gov/pubmed/26531194 http://dx.doi.org/10.1186/s40478-015-0245-8 |
work_keys_str_mv | AT zivkovicaleksandarr muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT sedlaczekoliver muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT vonhakenrebecca muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT schmidtkarsten muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT brennerthorsten muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT weigandmarkusa muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT badinghilmar muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT bengtsoncpeter muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity AT hoferstefan muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity |